Federated Hermes Inc. Has $1.71 Million Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Key Points

• Federated Hermes Inc. increased its stake in Establishment Labs Holdings Inc. by 28.2% in Q1, now owning approximately 0.15% of the company valued at $1.71 million.
• Several institutional investors, including Brown Advisory Inc. and Capital Research Global Investors, have also significantly increased their holdings in Establishment Labs, indicating strong institutional interest.
• Recent analyst reports have raised price targets for the company's stock, with Mizuho now setting a target at $70.00, reflecting a positive outlook for investors.

Federated Hermes Inc. raised its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 28.2% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,937 shares of the company's stock after acquiring an additional 9,217 shares during the period. Federated Hermes Inc. owned about 0.15% of Establishment Labs worth $1,711,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Brown Advisory Inc. raised its position in Establishment Labs by 23.1% in the fourth quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company's stock worth $107,729,000 after purchasing an additional 438,057 shares in the last quarter. Capital Research Global Investors boosted its holdings in Establishment Labs by 29.3% during the fourth quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock valued at $88,064,000 after purchasing an additional 433,484 shares in the last quarter. Findell Capital Management LLC grew its stake in shares of Establishment Labs by 28.5% in the 4th quarter. Findell Capital Management LLC now owns 1,346,480 shares of the company's stock valued at $62,032,000 after purchasing an additional 298,380 shares during the period. Rice Hall James & Associates LLC raised its holdings in shares of Establishment Labs by 7.4% in the 1st quarter. Rice Hall James & Associates LLC now owns 827,423 shares of the company's stock worth $33,763,000 after buying an additional 56,756 shares in the last quarter. Finally, Bamco Inc. NY raised its holdings in shares of Establishment Labs by 53.8% in the 4th quarter. Bamco Inc. NY now owns 752,886 shares of the company's stock worth $34,685,000 after buying an additional 263,500 shares in the last quarter. Institutional investors own 72.91% of the company's stock.

Analyst Ratings Changes

Several analysts recently commented on ESTA shares. BTIG Research began coverage on Establishment Labs in a research note on Friday, May 16th. They issued a "buy" rating and a $62.00 price target on the stock. Mizuho lifted their price objective on Establishment Labs from $58.00 to $70.00 and gave the company an "outperform" rating in a report on Wednesday, July 16th. Wall Street Zen raised shares of Establishment Labs from a "sell" rating to a "hold" rating in a report on Saturday, July 26th. Needham & Company LLC reiterated a "buy" rating and set a $48.00 target price on shares of Establishment Labs in a research report on Friday, June 13th. Finally, Citigroup boosted their price target on shares of Establishment Labs from $38.00 to $47.00 and gave the company a "neutral" rating in a research report on Wednesday, July 9th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $55.80.

Establishment Labs Price Performance

Establishment Labs stock traded down $1.16 on Friday, reaching $34.80. The company's stock had a trading volume of 807,937 shares, compared to its average volume of 352,613. The business's fifty day moving average price is $40.82 and its 200 day moving average price is $36.97. The company has a debt-to-equity ratio of 5.72, a quick ratio of 2.05 and a current ratio of 3.36. The company has a market cap of $1.01 billion, a price-to-earnings ratio of -11.41 and a beta of 0.83. Establishment Labs Holdings Inc. has a twelve month low of $26.56 and a twelve month high of $50.85.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.54) by ($0.03). The business had revenue of $51.30 million during the quarter, compared to the consensus estimate of $50.80 million. Establishment Labs had a negative net margin of 49.89% and a negative return on equity of 199.06%. The business's quarterly revenue was up 16.1% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.62) earnings per share. Equities analysts expect that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.